ArticleTrials2025

StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.

Rajenki Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.